Suzhou Alphamab Co., Ltd.

Suzhou Alphamab Co., Ltd. logo
🇨🇳China
Ownership
Holding
Established
2008-11-06
Employees
-
Market Cap
-
Website
http://www.alphamab.com

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

First Posted Date
2024-08-23
Last Posted Date
2024-08-23
Lead Sponsor
Suzhou Alphamab Co., Ltd.
Target Recruit Count
111
Registration Number
NCT06569108
Locations
🇨🇳

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China

A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight

Phase 1
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
Suzhou Alphamab Co., Ltd.
Target Recruit Count
36
Registration Number
NCT06547775
Locations
🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

First Posted Date
2024-03-15
Last Posted Date
2024-03-15
Lead Sponsor
Suzhou Alphamab Co., Ltd.
Target Recruit Count
51
Registration Number
NCT06312475
Locations
🇨🇳

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China

Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

First Posted Date
2023-12-26
Last Posted Date
2023-12-29
Lead Sponsor
Suzhou Alphamab Co., Ltd.
Target Recruit Count
240
Registration Number
NCT06180889
Locations
🇨🇳

Shanghai Sixth People's Hospital, Shanghai, Shanghai, China

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

First Posted Date
2022-06-16
Last Posted Date
2024-07-31
Lead Sponsor
Suzhou Alphamab Co., Ltd.
Target Recruit Count
24
Registration Number
NCT05421429
Locations
🇨🇳

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China

🇨🇳

stitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China

A Study to Evaluate Effects of KN056 in Healthy Participants

First Posted Date
2022-05-23
Last Posted Date
2024-05-13
Lead Sponsor
Suzhou Alphamab Co., Ltd.
Target Recruit Count
46
Registration Number
NCT05385575
Locations
🇳🇿

Alexandra Cole, Christchurch, New Zealand

© Copyright 2024. All Rights Reserved by MedPath